These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 21435407)
1. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine. Tseng HF; Smith N; Sy LS; Jacobsen SJ Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407 [TBL] [Abstract][Full Text] [Related]
2. Concomitant administration of pneumococcal-23 and zoster vaccines provides adequate herpes zoster coverage. Wyman MJ; Stabi KL Ann Pharmacother; 2013; 47(7-8):1064-8. PubMed ID: 23715069 [TBL] [Abstract][Full Text] [Related]
3. Vaccination against zoster remains effective in older adults who later undergo chemotherapy. Tseng HF; Tartof S; Harpaz R; Luo Y; Sy LS; Hetcher RC; Jacobsen SJ Clin Infect Dis; 2014 Oct; 59(7):913-9. PubMed ID: 25097079 [TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster. Mills R; Tyring SK; Levin MJ; Parrino J; Li X; Coll KE; Stek JE; Schlienger K; Chan IS; Silber JL Vaccine; 2010 Jun; 28(25):4204-9. PubMed ID: 20416263 [TBL] [Abstract][Full Text] [Related]
5. Real-World Evidence for Regulatory Decisions: Concomitant Administration of Zoster Vaccine Live and Pneumococcal Polysaccharide Vaccine. Bruxvoort K; Sy LS; Luo Y; Tseng HF Am J Epidemiol; 2018 Sep; 187(9):1856-1862. PubMed ID: 29659663 [TBL] [Abstract][Full Text] [Related]
6. Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population. Tseng HF; Chi M; Smith N; Marcy SM; Sy LS; Jacobsen SJ J Infect Dis; 2012 Jul; 206(2):190-6. PubMed ID: 22669900 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease. Tseng HF; Luo Y; Shi J; Sy LS; Tartof SY; Sim JJ; Hechter RC; Jacobsen SJ Clin Infect Dis; 2016 Feb; 62(4):462-7. PubMed ID: 26671505 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Pellissier JM; Brisson M; Levin MJ Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938 [TBL] [Abstract][Full Text] [Related]
9. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Lu PJ; Euler GL; Jumaan AO; Harpaz R Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175 [TBL] [Abstract][Full Text] [Related]
10. Vaccination: a new option to reduce the burden of herpes zoster. Mick G Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium. Bilcke J; Marais C; Ogunjimi B; Willem L; Hens N; Beutels P Vaccine; 2012 Jan; 30(3):675-84. PubMed ID: 22120193 [TBL] [Abstract][Full Text] [Related]
12. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study. Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC Vaccine; 2004 May; 22(15-16):2006-12. PubMed ID: 15121313 [TBL] [Abstract][Full Text] [Related]
13. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. Tseng HF; Smith N; Harpaz R; Bialek SR; Sy LS; Jacobsen SJ JAMA; 2011 Jan; 305(2):160-6. PubMed ID: 21224457 [TBL] [Abstract][Full Text] [Related]
14. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands. de Boer PT; Pouwels KB; Cox JM; Hak E; Wilschut JC; Postma MJ Vaccine; 2013 Feb; 31(9):1276-83. PubMed ID: 23306360 [TBL] [Abstract][Full Text] [Related]
16. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status. Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911 [TBL] [Abstract][Full Text] [Related]
17. Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old. MacIntyre CR; Egerton T; McCaughey M; Parrino J; Campbell BV; Su SC; Pagnoni MF; Stek JE; Xu J; Annunziato PW; Chan IS; Silber JL Hum Vaccin; 2010 Nov; 6(11):894-902. PubMed ID: 20980796 [TBL] [Abstract][Full Text] [Related]
18. Increased incidence of herpes zoster among patients with systemic lupus erythematosus. Chakravarty EF; Michaud K; Katz R; Wolfe F Lupus; 2013 Mar; 22(3):238-44. PubMed ID: 23257402 [TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older. Kerzner B; Murray AV; Cheng E; Ifle R; Harvey PR; Tomlinson M; Barben JL; Rarrick K; Stek JE; Chung MO; Schödel FP; Wang WW; Xu J; Chan IS; Silber JL; Schlienger K J Am Geriatr Soc; 2007 Oct; 55(10):1499-507. PubMed ID: 17908055 [TBL] [Abstract][Full Text] [Related]
20. Risk factors of herpes zoster among children immunized with varicella vaccine: results from a nested case-control study. Tseng HF; Smith N; Marcy SM; Sy LS; Chao CR; Jacobsen SJ Pediatr Infect Dis J; 2010 Mar; 29(3):205-8. PubMed ID: 19952977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]